tiprankstipranks
Trending News
More News >
Cawachi Limited (JP:2664)
:2664
Japanese Market

Cawachi Limited (2664) AI Stock Analysis

Compare
0 Followers

Top Page

JP:2664

Cawachi Limited

(2664)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 5.2)
Rating:72Outperform
Price Target:
¥3,341.00
▲(10.45% Upside)
Action:ReiteratedDate:08/21/25
Cawachi Limited's strong financial position and reasonable valuation are the primary strengths, contributing to a solid overall score. The technical analysis indicates stability but lacks strong momentum, while the absence of earnings call and corporate events data limits additional insights.
Positive Factors
Strong balance sheet
Low leverage and a high equity ratio provide lasting financial flexibility, reducing refinancing and solvency risk. This positions the company to withstand industry shocks, fund store operations or selective investment, and support stable operations over the next several months.
Improving cash generation
A strong increase in free cash flow and an operating cash flow to net income ratio above 1 indicate improving cash quality and operating conversion. Durable cash generation enhances ability to fund capex, maintain dividends, and reduce reliance on external funding.
Revenue stability & cost control
Consistent top-line and steady gross margins reflect durable demand and effective procurement/expense management in retail pharmacy. Stable revenues and margin control support predictable cash flows and operational planning over a multi-month horizon.
Negative Factors
Low net profitability
Very thin net and operating margins mean limited buffer against cost inflation or sales weakness. Persistent low profitability constrains reinvestment, reduces retained earnings growth, and makes returns sensitive to small adverse changes in revenues or expenses.
Declining EPS growth
A steep year-over-year EPS decline signals earnings pressure that may reflect margin compression, one-offs, or lower volumes. If earnings recovery lags, it limits cash available for strategic initiatives and weakens long-term return prospects for shareholders.
Weak FCF conversion
Free cash flow converts only ~70% of reported net income, indicating cash generation lag versus accounting profits. This reduces the practical funds available for dividends, debt paydown, or reinvestment, constraining financial flexibility despite improving headline FCF.

Cawachi Limited (2664) vs. iShares MSCI Japan ETF (EWJ)

Cawachi Limited Business Overview & Revenue Model

Company DescriptionCawachi Limited manages drugstores in Japan. The company retails pharmaceuticals, health foods, childcare products, cosmetics, daily miscellaneous goods, general food products, confectionery products, etc. It also involved in the insurance business. The company operates 355 drugstores. Cawachi Limited was founded in 1967 and is headquartered in Oyama, Japan.
How the Company Makes MoneyCawachi Limited primarily makes money through retail sales at its drugstore locations. Its main revenue stream comes from selling (1) prescription-related and over-the-counter pharmaceutical products, (2) health and beauty products (e.g., personal care and cosmetics), and (3) everyday household and convenience goods (e.g., toiletries and other daily necessities). The company’s earnings are driven by customer traffic and repeat purchases across these categories, with revenue recognized at the point of sale through its store network. Specific details on revenue mix by category, private-label contribution, e-commerce contribution, supplier rebate/allowance structures, and named strategic partnerships are null.

Cawachi Limited Financial Statement Overview

Summary
Cawachi Limited demonstrates stable revenue growth and strong cost control, with a solid balance sheet indicating low leverage and high equity. However, profitability and cash flow efficiency need improvement.
Income Statement
78
Positive
Cawachi Limited's income statement shows a stable revenue growth with a 0.65% increase from the previous year. The gross profit margin is consistent at around 23.2%, indicating strong cost management and efficiency. However, the net profit margin is relatively low at approximately 1.7%, suggesting limited profitability. The EBIT margin is low at 2.6%, but the EBITDA margin is slightly better at 3.9%, showcasing some operational efficiency. Overall, the company demonstrates stable revenue growth and strong cost control, but profitability remains a concern.
Balance Sheet
85
Very Positive
The balance sheet of Cawachi Limited displays a solid financial structure with a debt-to-equity ratio of 0.15, indicating low leverage. The return on equity is stable at 4.3%, showing efficient use of equity to generate profits. The equity ratio is strong at 57.3%, reflecting financial stability and a low reliance on debt. Overall, the balance sheet indicates a strong financial position with low leverage and high equity.
Cash Flow
72
Positive
Cawachi Limited's cash flow statement shows a significant improvement in free cash flow, with a growth rate of 232.5% from the previous year. The operating cash flow to net income ratio is 1.53, demonstrating strong cash generation relative to net income. However, the free cash flow to net income ratio is lower at 0.70, indicating some challenges in converting income into free cash flow. The cash flow position is improving, but there remains room for better conversion of earnings to free cash flow.
BreakdownTTMMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Income Statement
Total Revenue287.50B287.82B285.96B281.87B279.46B284.49B
Gross Profit66.44B66.66B65.80B64.05B63.15B64.68B
EBITDA10.85B11.36B11.49B10.90B12.16B15.17B
Net Income4.75B4.88B4.71B4.18B4.83B7.11B
Balance Sheet
Total Assets203.63B200.96B197.24B195.24B192.48B194.86B
Cash, Cash Equivalents and Short-Term Investments40.72B36.67B35.62B38.45B38.96B41.23B
Total Debt17.92B16.60B16.73B19.55B22.92B26.41B
Total Liabilities89.95B86.55B85.94B87.51B87.83B94.00B
Stockholders Equity113.68B114.41B111.30B107.72B104.65B100.86B
Cash Flow
Free Cash Flow0.003.40B1.02B4.11B2.37B12.09B
Operating Cash Flow0.007.48B6.40B9.82B6.87B15.27B
Investing Cash Flow0.00-4.51B-5.29B-5.84B-4.54B-3.15B
Financing Cash Flow0.00-1.92B-3.94B-4.49B-4.61B-3.98B

Cawachi Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3025.00
Price Trends
50DMA
3006.48
Negative
100DMA
2945.52
Positive
200DMA
2844.47
Positive
Market Momentum
MACD
-15.18
Positive
RSI
47.90
Neutral
STOCH
31.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:2664, the sentiment is Positive. The current price of 3025 is below the 20-day moving average (MA) of 3035.56, above the 50-day MA of 3006.48, and above the 200-day MA of 2844.47, indicating a neutral trend. The MACD of -15.18 indicates Positive momentum. The RSI at 47.90 is Neutral, neither overbought nor oversold. The STOCH value of 31.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:2664.

Cawachi Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
¥649.49B23.2915.71%0.96%21.81%67.76%
72
Outperform
¥66.76B16.622.68%-0.56%5.59%
69
Neutral
¥458.11B14.0511.37%3.04%6.32%8.19%
67
Neutral
¥1.05T25.311.72%
67
Neutral
¥351.10B20.790.41%15.81%27.05%
60
Neutral
¥527.83B22.790.93%3.73%18.84%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:2664
Cawachi Limited
2,991.00
260.71
9.55%
JP:9989
Sundrug Co
3,918.00
-180.54
-4.41%
JP:7649
Sugi Holdings Co
3,446.00
659.17
23.65%
JP:3391
TSURUHA Holdings
2,339.50
498.16
27.05%
JP:3349
COSMOS Pharmaceutical Corporation
6,631.00
-761.06
-10.30%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,672.00
353.42
10.65%

Cawachi Limited Corporate Events

Cawachi Limited Posts Profit Decline but Boosts Anniversary Dividend Amid Stable Financial Base
Jan 27, 2026

Cawachi Limited reported consolidated net sales of ¥214.99 billion for the nine months ended December 15, 2025, down 0.9% year on year, with operating profit falling 20.0% to ¥4.62 billion and profit attributable to owners of parent declining 13.1% to ¥3.47 billion, reflecting margin pressures and a weaker earnings profile despite stable overall scale. The company’s financial position remained robust with total assets of ¥205.10 billion and an equity-to-asset ratio of 56.6%, and it plans to raise its full-year dividend to ¥100 per share, including a ¥20 commemorative payout for its 65th anniversary, even as it forecasts slightly lower full-year sales and a more than 20% drop in full-year profit, signaling a commitment to shareholder returns amid a challenging earnings environment.

The most recent analyst rating on (JP:2664) stock is a Buy with a Yen3441.00 price target. To see the full list of analyst forecasts on Cawachi Limited stock, see the JP:2664 Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 21, 2025